Table_1_Quantitative evaluation of traditional Chinese medicine development policy: A PMC index model approach.DOCX

BackgroundTraditional Chinese medicine development policies (TCMDPs) are essential in improving the sustainable development of TCM undertakings, of which transmissions of policy information are closely related to the actual policy effectiveness. However, the inherent components of TCMDPs had not been explored from the structural dimension of policy design.
MethodsBased on the policy modeling consistency (PMC) index model, we constructed a comprehensive evaluation system, including ten first-level and 40 second-level indicators, and focused on the TCMDPs released by the Chinese central government in the past 42 years (1980–2022) to conduct multi-dimensional inspections to TCMDPs by analyzing the overall policy quality, individual scoring performance, and indicators distribution characteristics.
ResultsThis study pointed out that four policies were rated as “perfect,” 35 were rated as “superb,” 50 were rated as “excellent,” 28 were rated as “good,” and four were rated as “acceptable,” with total mean values of the PMC index being 7.530 ± 0.835. Although most TCMDPs had appropriate policy structure and consistency, the potential weaknesses in the design of TCMDPs also needed our attention through careful checks on the outlier policy samples. Besides, the existing TCMDPs had room for improvement regarding policy areas, guarantees and incentives, objects included, and issuing agencies.
ConclusionsWe emphasized that the policy evaluation method used in this current study, the PMC index model, is scarce in the TCMDPs. These findings are helpful for fully understanding the strengths and weaknesses of TCMDPs and provide theoretical references for further studies optimizing TCMDPs.

背景 中医药发展政策（Traditional Chinese Medicine Development Policies, TCMDPs）是推动中医药事业可持续发展的核心支撑，其政策信息的传播与政策实际效能紧密相关。然而，此前尚未有研究从政策设计的结构维度，对中医药发展政策的内在构成展开探索。
方法 基于政策建模一致性（Policy Modeling Consistency, PMC）指数模型，本研究构建了包含10个一级指标、40个二级指标的综合评价体系，以1980—2022年即近42年间中国中央政府发布的中医药发展政策为研究对象，通过分析政策整体质量、单项得分表现与指标分布特征，对中医药发展政策开展多维度检视。
结果 本研究显示，共有4项政策获评“完美”、35项获评“优异”、50项获评“优秀”、28项获评“良好”、4项获评“合格”，政策建模一致性指数的总体均值为7.530±0.835。尽管多数中医药发展政策具备合理的结构与一致性，但通过对异常政策样本的细致核查，仍可发现政策设计中存在的潜在短板。此外，现有中医药发展政策在政策覆盖领域、保障与激励机制、政策受众及发文主体等方面仍存在优化空间。
结论 本研究强调，政策建模一致性指数模型这一政策评价方法在中医药发展政策领域的应用尚属少见。本研究结果有助于全面认知中医药发展政策的优势与不足，可为后续优化中医药发展政策的相关研究提供理论参考。